Sodium Chloride
- Product NDC
- 70369-010
- 11-digit product format
- 703690010
- Labeler code
- 70369
- Product ID
- 70369-010_2ce80e1e-5259-596d-e063-6294a90add01
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sodium Chloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Citragen Pharmaceuticals Inc
- Application
- M018
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-07-20
- Substance
- SODIUM CHLORIDE
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 70369-010-09 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 70369-010-09 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70369-010-09 | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sodium Chloride
- Brand name suffix
- Normal Salt
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SODIUM CHLORIDE | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 451W47IQ8X | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2387545 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| aae783b2-18fe-69ca-e053-2a95a90a0800 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70369-010-09 | 2025-02-01 | C162847 | 48780-1 | 2cef2736-7a92-d83d-e063-dadaa90ab31f | Sodium Chloride Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70369-010-09 | Sodium ChlorideNormal Salt | 200 in 1 BOTTLE | TABLET | 200 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rugby Lubricating Drops | POLYVINYL ALCOHOL | A-S Medication Solutions | f2e26f85-4081-425b-9c81-ac2a079a5743 | 2023-11-10 | Warnings | M018 |
| Saline | NASAL | GERI-CARE PHARMACEUTICAL CORP | d293cc13-4043-0d58-e053-2995a90a3fbc | 2023-10-24 | Warnings | M018 |
| Eyeganics Organic Tears | GLYCERIN | Eyeganics LLC | 42470af7-a3ae-4e14-88e0-04cd92db4b37 | 2023-10-13 | Warnings | M018 |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | M018 |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | M018 |
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | M018 |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-15 | Warnings | M018 |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | M018 |
| REFRESH TEARS | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 329d1fe0-4432-4565-b7b1-65666bd86526 | 2022-06-30 | Warnings | M018 |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | M018 |
| REFRESH P.M. | MINERAL OIL, PETROLATUM | Allergan, Inc. | 24365d64-cd94-41cc-a7e1-033102d98114 | 2022-06-30 | Warnings | M018 |
| REFRESH PLUS | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 0f6a4b4b-cde6-4518-84b5-ce997f1154a7 | 2022-06-28 | Warnings | M018 |
| CIRCLE K sterile eye drops | TETRAHYDROZOLINE HCL | Lil' Drug Store Products, Inc. | 2c0e106c-16f6-ff4e-e063-6294a90a7dbb | 2018-07-30 | Warnings | M018 |
| Lil Drug Store Sterile Eye Drops Redness Reliever | TETRAHYDROZOLINE HCL | Lil' Drug Store Products, Inc. | 2c0ea35c-ac52-1043-e063-6394a90a061c | 2018-04-30 | Warnings | M018 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2387545 | sodium chloride 500 MG Oral Tablet | PSN | aae783b2-18fe-69ca-e053-2a95a90a0800 | 3 |
| 2387545 | sodium chloride 500 MG Oral Tablet | SCD | aae783b2-18fe-69ca-e053-2a95a90a0800 | 3 |
| 2387545 | NaCl 500 MG Oral Tablet | SY | aae783b2-18fe-69ca-e053-2a95a90a0800 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70369-010-09 | 70369001009 | 200 TABLET in 1 BOTTLE (70369-010-09) | 200 tablet | 2020-07-20 | 0000-00-00 | No | No | Current |